Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV3I Grifols 10% in ITP
NCT00699140Phase 3Completed
- Sponsor
- Grifols
- Start
- Feb 2008
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in immune thrombocytopenic purpura (ITP), sponsored by Grifols. Started Feb 2008; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00699140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699140.